Key statistics
As of last trade BioNexus Gene Lab Corp (BGLC:NAQ) traded at 0.2912, 3.63% above its 52-week low of 0.281, set on Nov 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.300 |
---|---|
High | 0.305 |
Low | 0.2866 |
Bid | 0.294 |
Offer | 0.31 |
Previous close | 0.2919 |
Average volume | 90.81k |
---|---|
Shares outstanding | 17.97m |
Free float | 10.11m |
P/E (TTM) | -- |
Market cap | 5.24m USD |
EPS (TTM) | -0.0391 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 18:52 GMT.
More ▼
- BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd.
- BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd.
- BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions
- BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production
- BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd
- BioNexus Gene Lab Corp. Completes Strategic RM 1 Million Investment in Ascension Innovation Sdn Bhd
- BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare
More ▼